Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Bridge Biotherapeutics Inc. (KR)

Bridge Biotherapeutics Inc., based in South Korea, US and China is a clinical stage, virtually operated biotech company founded in 2015. Bridge Biotherapeutics is engaged in the discovery and development of novel therapeutics, focusing on therapeutic areas with high-unmet needs, such as ulcerative colitis, fibrotic diseases, and cancers. Following its first compound BBT-401, the first-in-class Pellino-1 inhibitor for treatment of ulcerative colitis currently in Phase II in the US, Bridge Biotherapeutics is developing BBT-877 for treatment of various fibrosing interstitial lung diseases including idiopathic pulmonary fibrosis (IPF). The candidate has been originally discovered by LegoChem Biosciences and was licensed to Bridge Biotherapeutics in 2017 for the worldwide exclusive right for further development. BBT-176, a potent targeted cancer therapy for non–small cell lung cancer (NSCLC) is also in development. Bridge Biotherapeutics is a resident company of JLABS @ Shanghai. *

 

Period Start 2015-01-01 established
Products Industry drug development
  Industry 2 autotaxin inhibitor
     
  Street Suite 903-2, Bldg B, Innovalley, 253 Pangyo-ro, Bundang-gu
  City 13486 Seongnam-si, Gyeonggi-do
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: Boehringer Ingelheim. (7/18/19). "Press Release: Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics". Ingelheim & Seongnam.
     
   
Record changed: 2020-08-12

Advertisement

Picture [iito] Made Without Love 650x80px

More documents for Bridge Biotherapeutics Inc. (KR)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top